Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.
企業コードCYRX
会社名Cryoport Inc
上場日Jul 24, 2015
最高経営責任者「CEO」Mr. Jerrell Wilson (Jerry) Shelton
従業員数1090
証券種類Ordinary Share
決算期末Jul 24
本社所在地112 Westwood Place, Suite 350
都市BRENTWOOD
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号37027
電話番号19492321900
ウェブサイトhttps://www.cryoport.com/
企業コードCYRX
上場日Jul 24, 2015
最高経営責任者「CEO」Mr. Jerrell Wilson (Jerry) Shelton
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし